These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5354854)

  • 21. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
    Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
    Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
    [No Abstract]   [Full Text] [Related]  

  • 23. New and OLD DRUGS FOR PARKINSONISM.
    Med Lett Drugs Ther; 1968 Sep; 10(18):69-72. PubMed ID: 5730145
    [No Abstract]   [Full Text] [Related]  

  • 24. Specific therapy in Parkinson's disease.
    Med J Aust; 1970 Oct; 2(14):612-3. PubMed ID: 5477804
    [No Abstract]   [Full Text] [Related]  

  • 25. Aromatic amino acids and modification of parkinsonism.
    Cotzias GC; Van Woert MH; Schiffer LM
    N Engl J Med; 1967 Feb; 276(7):374-9. PubMed ID: 5334614
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG; Kistenev BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment of parkinsonism. Current concepts.
    Yahr MD
    Med Clin North Am; 1972 Nov; 56(6):1377-92. PubMed ID: 4117524
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic uses and side effects of L-dopa.
    Boshes B
    Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081
    [No Abstract]   [Full Text] [Related]  

  • 29. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
    Calne DB; Reid JL; Vakil SD; Rao S; Petrie A; Pallis CA; Gawler J; Thomas PK; Hilson A
    Br Med J; 1971 Sep; 3(5777):729-32. PubMed ID: 4938431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse reactions during treatment of Parkinson's disease with levodopa.
    Martin WE
    JAMA; 1971 Jun; 216(12):1979-83. PubMed ID: 5314258
    [No Abstract]   [Full Text] [Related]  

  • 31. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L; Martin JD; Gutrecht JA
    W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660
    [No Abstract]   [Full Text] [Related]  

  • 32. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F; Grünberger J; Schubert H
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract]   [Full Text] [Related]  

  • 34. L-dopa. II.
    Br Med J; 1970 Nov; 4(5734):541-2. PubMed ID: 4099003
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinsonism and dopa.
    N Z Med J; 1969 May; 69(444):306-7. PubMed ID: 5256210
    [No Abstract]   [Full Text] [Related]  

  • 36. [Levodopa and Parkinsonism. A double-blind study].
    Pakkenberg H; Dupont E; Garde B; Hansen E; Melsen S; Vestberg F
    Ugeskr Laeger; 1971 Nov; 133(46):2275-9. PubMed ID: 4944650
    [No Abstract]   [Full Text] [Related]  

  • 37. Levodopa in postencephalitic parkinsonism.
    Hunter KR; Stern GM; Sharkey J
    Lancet; 1970 Dec; 2(7687):1366-7. PubMed ID: 4098944
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of Levo-Dopa in the treatment of Parkinsonism (188 cases)].
    Fasano VA; Urciuoli R; Broggi G; Lombard GF
    Minerva Neurochir; 1970; 14(2):245-9. PubMed ID: 5515308
    [No Abstract]   [Full Text] [Related]  

  • 39. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].
    Wälzholz U; Schönfelder H
    Nervenarzt; 1972 Oct; 43(10):531-2. PubMed ID: 4628192
    [No Abstract]   [Full Text] [Related]  

  • 40. Measurement of rigidity and tremor in Parkinson's disease.
    Aquilonius SM; Tiselius P
    Acta Neurol Scand; 1969; 45(3):327-34. PubMed ID: 5807452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.